<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="0.91"><channel><title>Latest co-operation profiles - Diagnostics from Scotent</title><link>http://www.enterprise-europe-scotland.com</link><image><title><![CDATA[Latest co-operation profiles - Diagnostics from Scotent]]></title><url>/sct/assets/images/sitelook/een.gif</url><link></link></image>
<item>
<title><![CDATA[Nanofluidic devices for biomedical application]]></title>
<pubDate>Fri, 3 Feb 2012 00:00:01 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 11 IT 52T6 3KYQ <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>An Italian company dealing with design,development and production of micro and nanofluidic for biological and medical applications such as separation,preconcentration,detection of biomolecules(proteins and DNA) has developed innovative nanofabrication technologies. Such solutions can be easily integrated in more complex platforms and allow the production of low cost nanostructured devices. The company is looking for joint further development, testing of new applications and financial resources.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 IT 52T6 3KYQ&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 IT 52T6 3KYQ&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Unique and world leading capabilities in natural product sourcing, genomics and target-based drug screening]]></title>
<pubDate>Fri, 3 Feb 2012 00:00:02 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 GB 47P8 3O0I <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A drug discovery company (SME) based in North East of England wishes to offer its unique and world leading capabilities in natural product sourcing, genomics and target-based drug screening.SME also wishes to offer its exceptionally diverse collection of actinomycete bacteria, many of which are expected to produce bio-active molecules of different kinds against a range of high value targets, including drugs.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 GB 47P8 3O0I&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 GB 47P8 3O0I&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[An osmotic cartridge for intraoral drug delivery]]></title>
<pubDate>Thu, 2 Feb 2012 00:00:03 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 11 DE 1377 3NBM <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A German R&amp;D institute has developed a novel dental prosthesis for high-precision and continous intraoral drug delivery. Its osmotic principle requires no electrical power. The cartridge is integrated into two buccal teeth of a removable partial denture. It was originally developed for the therapy of Parkinson patients. The R&amp;D institute is now looking for industrial/academic partners for the transfer to drug delivery applications beyond Parkinson's Disease.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 DE 1377 3NBM&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 DE 1377 3NBM&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Technology line for curd cheese production]]></title>
<pubDate>Thu, 2 Feb 2012 00:00:04 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 11 PL 62AQ 3NOC <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>Company from North-East Poland, dairy producer, developed technology line for curd cheese production. 
Offered technology line is characterized by a high level of production hygiene, low energy consumption and high level automation of production process. The company is interested in manufacturing agreement or commercial agreement with technical assistance.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 PL 62AQ 3NOC&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 PL 62AQ 3NOC&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Automatic Formalin Dispensing System for Laboratories]]></title>
<pubDate>Thu, 2 Feb 2012 00:00:05 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 TR 99PB 3O03 <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A Turkish company specialized in the manufacturing of pathology and microbiology equipments developed a dispensing device for obtaining formalin in a given concentrate. This device can be used in every laboratory using formalin such as pathology, histology laboratories and it prevents the harmful effects of formalin to human health. The company is looking for commercial agreement with technical assistance to adapt the device to partners needs.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 TR 99PB 3O03&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 TR 99PB 3O03&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Implementation of an analytic system for the detection of allergens.]]></title>
<pubDate>Wed, 1 Feb 2012 00:00:06 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 11 ES 23C6 3NE7 <span style="background-color:GREEN;color:white;padding:3px;">REQUEST</span></strong><br><br>A Spanish company that belongs to the ground spices sector manufactures paprika, various spices and mixes for cold cuts. The sought technology is an analytical system for detecting several types of allergens in its products in a quick and accurate way. Nowadays they solve this problem sending samples to an external laboratory. This analytic system must detect the allergen families that affect typically the paprika and the ground spices (between 10 and 15 types).]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 ES 23C6 3NE7&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 ES 23C6 3NE7&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[System for automation of manufacturing plant paprika and spices.]]></title>
<pubDate>Wed, 1 Feb 2012 00:00:07 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 11 ES 23C6 3NEA <span style="background-color:GREEN;color:white;padding:3px;">REQUEST</span></strong><br><br>A Spanish company that belongs to the ground spices sector manufactures paprika, various spices and mixes for cold cuts. In order to improve its production process they are aiming to update the machinery, looking for the automation from the mixing to the palletizing, besides the transport, grinding, dosage, packaging, etc. As a requirement, the sought machinery must be easy to clean as it works with several types of spices and colours.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 ES 23C6 3NEA&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 ES 23C6 3NEA&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Genetic and epigenetic testing based on HRM method]]></title>
<pubDate>Tue, 31 Jan 2012 00:00:08 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 EE 21B9 3NVH <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>An Estonian SME has developed competences in HRM (High Resolution Melting) based genetic and epigenetic analyzing to medical and research laboratories. The method is fast, sensitive and cost-effective, enabling to detect specific variations even with relatively low incidence. Technical Cooperation or Commercial Agreement with Technical Assistance is sought.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 EE 21B9 3NVH&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 EE 21B9 3NVH&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[In Vivo Models Linking Autotaxin Inhibition to a Disease]]></title>
<pubDate>Tue, 31 Jan 2012 00:00:09 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 LU 87GA 3NZZ <span style="background-color:GREEN;color:white;padding:3px;">REQUEST</span></strong><br><br>A large US company is looking for proposals for validated in vivo models able to link inhibition of autotoxin (ATX) activity and decline of lysophosphatidic acid (LPA) levels to the reduction of clinically relevant biomarkers, preferably, but not limited to oncology, immune-mediated diseases, or fibrosis.
They are interested in contract research, joint development license agreement.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 LU 87GA 3NZZ&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 LU 87GA 3NZZ&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Biofluid based Health Measurement Technology]]></title>
<pubDate>Tue, 31 Jan 2012 00:00:10 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 LU 87GA 3O1W <span style="background-color:GREEN;color:white;padding:3px;">REQUEST</span></strong><br><br>A large US company is looking for proposals for health measurement technology based on non-invasive collection and analysis of bio-fluid other than blood. Of interest are technologies for hand-held devices that are easy to use.
They are interested in development contract, joint development, OEM/ODM.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 LU 87GA 3O1W&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 LU 87GA 3O1W&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Ultra-miniaturized room temperature electrically driven continuous wave THz source for mobile and compact applications]]></title>
<pubDate>Fri, 27 Jan 2012 00:00:11 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 CH 84FB 3NZQ <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A Swiss company - the valorization partner of a European FP7 consortium - is looking for companies with products where a low cost ultra-compact narrow line width terahertz (THz) source would be an enabling technology for bio-sensing or near-field imaging applications. The aim is to customize the source in development toward end-user specific needs and to offer the opportunity to use the resulting source for field tests and eventually perform a technology transfer.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 CH 84FB 3NZQ&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 CH 84FB 3NZQ&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Receptor-Tyrosine Kinase Inhibitors - Inhibitors of Uncontrolled Cell Replication and Other Diseases Caused by Receptor-Tyrosine Kinase]]></title>
<pubDate>Fri, 27 Jan 2012 00:00:12 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 DE 1380 3O09 <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A large German Research Institute has investigated and elucidated the effect of receptor-tyrosine kinase inhibitors which inhibit uncontrolled cell replications and other diseases caused by receptor-tyrosin kinase. This inhibitor is applicable in biotechnology or pharmaceutical industry. The institute seeks either a license agreement or a joint further development.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 DE 1380 3O09&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 DE 1380 3O09&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Fenugreek seed extracts for foodstuffs]]></title>
<pubDate>Fri, 27 Jan 2012 00:00:13 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 DK 20B7 3NWV <span style="background-color:GREEN;color:white;padding:3px;">REQUEST</span></strong><br><br>A Danish consultant has patented a specific method to extract active compounds from fenugreek seeds which can be used in foodstuffs. Various SMEs are sought for technical cooperation: a dietitian/nutritionist company (directing efforts to the diabetic area - old peoples' homes and hospitals) and a diary company who produces yoghurts. Plus a food formulator who is to bring the products to the market (marketing).]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 DK 20B7 3NWV&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 DK 20B7 3NWV&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Method for selecting neuronal cells based on their differentiation through exposure to flubendiamide]]></title>
<pubDate>Fri, 27 Jan 2012 00:00:14 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 ES 24D4 3O0Y <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A Spanish university research group has developed a technology related to a process for the selection of neuronal cells in culture in terms of their differentiation, through the establishment of a dose-response relation by adding different concentrations of flubendiamide to several groups of nerve cells. Companies from agribusiness, chemical or pharmaceutical fields, and in antitumor or neuro-regenerative therapies, are sought for license agreements.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 ES 24D4 3O0Y&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 ES 24D4 3O0Y&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[New methods for enriching adult-derived endothelial progenitor cells]]></title>
<pubDate>Fri, 27 Jan 2012 00:00:15 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 FI 30I0 3NZJ <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A Finnish research group has identified and isolated previously unknown CD117+ adult vascular endothelial stem cells (VESCs), which could be used in cell-based therapies to restore tissue vascularization in ischemic situation such as atherosclerosis and coronary artery disease. These cells are also the true biological target for all existing and future anti-angiogenic therapies. The researchers are looking for biotech or pharmaceutical companies for R&amp;D partnership and out-licensing.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 FI 30I0 3NZJ&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 FI 30I0 3NZJ&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[A novel immunomodulatory peptide that can be used for treatment of infectious diseases, Cardiovascular Ischemia/Reperfusion injury, Acute Kidney Injury and Multiple Myeloma]]></title>
<pubDate>Fri, 27 Jan 2012 00:00:16 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 IL 80EP 3O1C <span style="background-color:GREEN;color:white;padding:3px;">REQUEST</span></strong><br><br>An Israeli clinical stage biotechnology company is looking for a partner to collaborate on developing its lead compound, a short peptide antagonist of CD28, for treatment of immune related diseases. The company is seeking to collaborate with service providers, academic researchers and clinical investigators in the fields of drug development (preclinical and clinical) in the area of Cardiovascular Ischemia reperfusion injury and multiple myeloma.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 IL 80EP 3O1C&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 IL 80EP 3O1C&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Advantageous and innovative synthesis process of zeolite from fly ash at low temperature]]></title>
<pubDate>Fri, 27 Jan 2012 00:00:17 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 IT 53U1 3O04 <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A relevant Italian research centre has developed an innovative process of zeolite synthesis from fly ash at very low temperature by using seawater. The process represents a concrete potential application to obtain industrial products from waste material with economical advantages. The centre is looking for support in scientific research and in practical application. The partners sought are industries and research organisations in the field of: environmental monitoring; cement; nano-materials.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 IT 53U1 3O04&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 IT 53U1 3O04&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Adaptable, PC-controlled biotechnological improvements for Polymerase Chain Reactions, Elektrophoresis, Bio-Imaging, and Radioanalystics]]></title>
<pubDate>Thu, 26 Jan 2012 00:00:18 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 11 DE 093I 3NFX <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A SME from Saxony specialized in PCR (Polymerase Chain Reaction), elektrophoresis, bio-imaging, and radioanalystics is offering technical cooperation for innovative implementation of PC-controled gel domcumentation systems. R&amp;D processes and results assure new dimensions of transparency. The improvement of existing quality control management systems is offered via a Commercial Agreement with Technical Assistance.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 DE 093I 3NFX&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 DE 093I 3NFX&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Joint further development in the field of Polymerase Chain Reaction, Elektrophoresis, Bio-Imaging, and Radioanalystics]]></title>
<pubDate>Thu, 26 Jan 2012 00:00:19 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 11 DE 093I 3NFZ <span style="background-color:GREEN;color:white;padding:3px;">REQUEST</span></strong><br><br>A SME from Saxony specialized in PCR (Polymerase Chain Reaction), elektrophoresis, bio-imaging, and radioanalystics is requesting joint further development and is looking for partners interested in open innovation solutions and product-evolution of PC-controlled gel domcumentation systems. The creation of new market applications should focus on product development in the field of OEM (Original Equimpment Manufacturing).]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 DE 093I 3NFZ&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=11 DE 093I 3NFZ&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Heat exchanger with laminarisator for medical use.]]></title>
<pubDate>Thu, 26 Jan 2012 00:00:20 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 CZ 0746 3NYQ <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A Czech medical university has developed a heat exchanger with laminarisator enabling uniform laminar cooling and heating of fluids, especially of the blood. The heat exchanger efficiently eliminates undesirable coagulation of the blood during dialysis. The university is interested in licence agreement with companies producing disposable medical supplies from plastics.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 CZ 0746 3NYQ&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 CZ 0746 3NYQ&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[New generation of magnetic-fluorescent particles for biomedical applications.]]></title>
<pubDate>Thu, 26 Jan 2012 00:00:21 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 ES 23D2 3NYW <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A Spanish research group has developed a new generation of biomarkers based on magnetic and fluorescent properties. The hybrid bio-particles can be used for cell imaging and monitoring, drug delivery and biomarking according to specific requirements. The process is fully developed, patented and lab tests are available. The research group is looking for companies acquiring this technology for its exploitation, although it is open to other kind of collaboration.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 ES 23D2 3NYW&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 ES 23D2 3NYW&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Production of cells resistant to cytotoxic drugs for tissue regeneration.]]></title>
<pubDate>Wed, 25 Jan 2012 00:00:22 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 ES 27F4 3NXY <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>An Andalucian research group has developed and patented a technology for obtaining animal cell lines resistant to cytotoxic drugs that act by inhibiting the vacuolar ATPase. These cell lines may be the basis for restoring tissues and organs damaged by chemotherapy. Industrial partners interested in a patent license for the exploitation of the technology are sought.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 ES 27F4 3NXY&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 ES 27F4 3NXY&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Phi29-derived terminal protein-primed amplification of lineal DNA: a highly efficient system for DNA amplification and synthesis of protein-DNA hybrids.]]></title>
<pubDate>Wed, 25 Jan 2012 00:00:23 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 ES 28G2 3NY3 <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A Spanish public research organisation has devised a minimal system for in vitro terminal protein (TP)-primed amplification of lineal DNA. A 69-194 nucleotide sequence of the phage Phi29 DNA is attached to each end of the lineal DNA and high fidelity DNA copies, linked to TP are synthesized by adding Phi29 TP, DNA polymerase and two DNA binding proteins. Besides, TP-DNA is itself useful for protein-DNA applications. They look for biotechs to sell DNA-amplification kits under a patent licence.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 ES 28G2 3NY3&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 ES 28G2 3NY3&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Innovative dental implant solution]]></title>
<pubDate>Wed, 25 Jan 2012 00:00:24 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 SE 672F 3NUV <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A small, privately owned, company from southern Sweden has invented a new dental implant solution with a fitting superstructure. The implant solution fits the superstructure no matter what angel the surgeon is locating the implants in. The Swedish company is looking for strong strategic partners that could help them in bringing the product to the international market through joint venture or licence agreement.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 SE 672F 3NUV&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 SE 672F 3NUV&amp;EnquiryType=BBS</link>
</item>
<item>
<title><![CDATA[Attenuated influenza A virus for a live vaccine.]]></title>
<pubDate>Tue, 24 Jan 2012 00:00:25 GMT</pubDate>
<description><![CDATA[<strong>Technology collaboration - 12 DE 1486 3NWJ <span style="background-color:RED;color:white;padding:3px;">OFFER</span></strong><br><br>A technology transfer office in Bavaria represents a known German university. Its Institute of Molecular Virology focuses on intracellular signal transduction pathways and their impact on viral infection and inflammation. The investigators could show that the attenuation of influenza A viruses (IAV) by introduction of silent mutations into the nucleoprotein (NP) gene may serve as a strategy for a live attenuated vaccine. We are looking for a licensee.]]></description>
<category><![CDATA[Technology collaboration]]></category>
<guid isPermaLink="true">http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 DE 1486 3NWJ&amp;EnquiryType=BBS</guid>
<link>http://www.enterprise-europe-scotland.com/sct/rss/clickHandler.asp?mi=470&amp;id=12 DE 1486 3NWJ&amp;EnquiryType=BBS</link>
</item>
</channel></rss>

